We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Scotts Miracle-Gro Company (SMG - Free Report) posted net loss from continuing operations of $71.3 million or $1.28 per share in first-quarter fiscal 2020 (ended Dec 28, 2019). The figure is narrower than a loss of $82.6 million or $1.49 per share in the year-ago quarter.
Barring one-time items, adjusted loss per share was $1.12, narrower than a loss of $1.39 in the year-ago quarter. The figure was also narrower than the Zacks Consensus Estimate of a loss of $1.24.
Net sales rose 23% year over year to $365.8 million. The figure surpassed the consensus mark of $347.7 million.
Company-wide gross margin rate (as reported) rose to 14.8% from 11.6% in the year-ago quarter.
The Scotts Miracle-Gro Company Price, Consensus and EPS Surprise
In fiscal first quarter, net sales in the U.S. Consumer division rose 8% year over year to $147.4 million. The segment reported a loss of $41.5 million, which is narrower than a loss of $43.1 million in the year-ago quarter.
Net sales in the Hawthorne segment rose 41% year over year to $198.8 million in the reported quarter, which was primarily driven by strong demand in almost all categories of indoor growing equipment and supplies. The segment’s profit surged 216% year over year to $13.9 million.
Net sales in the Other segment fell 4% year over year to $19.6 million. The segment incurred a net loss of $3.5 million in the reported quarter, which is lower than a loss of $4 million in the year-ago quarter.
Balance Sheet
In fiscal first quarter, the company had cash and cash equivalents of $27.4 million, up 21.2% year over year. Long-term debt was $1,969.9 million, down 9.9% year over year.
Outlook
The company witnessed strong momentum in the U.S. Consumer unit in fiscal 2019, which also continued into fiscal 2020. Moreover, it continues to see outstanding performance across all product categories in the Hawthorne business in the United States.
Going forward, the company is upbeat on achieving its fiscal 2020 guidance. Scotts Miracle-Gro expects company-wide sales growth in the range of 4-6% for fiscal 2020. It continues to expect adjusted earnings per share in the band of $4.95-$5.15 for fiscal 2020.
Free cash flow is projected to be around $300 million.
Price Performance
Shares of Scotts Miracle-Gro have surged 61.8% in the past year against the industry’s 18.2% decline.
Zacks Rank & Key Picks
Scotts Miracle-Gro currently carries a Zacks Rank #3 (Hold).
Daqo New Energy has projected earnings growth rate of 326.3% for 2020. The company’s shares have rallied 44.3% in the past year.
Royal Gold has an estimated earnings growth rate of 83.5% for fiscal 2020. Its shares have returned 32.5% in the past year.
Sibanye Gold has an expected earnings growth rate of 587.5% for 2020. The company’s shares surged 213.8% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Scotts Miracle-Gro (SMG) Q1 Earnings & Sales Beat Estimates
The Scotts Miracle-Gro Company (SMG - Free Report) posted net loss from continuing operations of $71.3 million or $1.28 per share in first-quarter fiscal 2020 (ended Dec 28, 2019). The figure is narrower than a loss of $82.6 million or $1.49 per share in the year-ago quarter.
Barring one-time items, adjusted loss per share was $1.12, narrower than a loss of $1.39 in the year-ago quarter. The figure was also narrower than the Zacks Consensus Estimate of a loss of $1.24.
Net sales rose 23% year over year to $365.8 million. The figure surpassed the consensus mark of $347.7 million.
Company-wide gross margin rate (as reported) rose to 14.8% from 11.6% in the year-ago quarter.
The Scotts Miracle-Gro Company Price, Consensus and EPS Surprise
The Scotts Miracle-Gro Company price-consensus-eps-surprise-chart | The Scotts Miracle-Gro Company Quote
Segment Details
In fiscal first quarter, net sales in the U.S. Consumer division rose 8% year over year to $147.4 million. The segment reported a loss of $41.5 million, which is narrower than a loss of $43.1 million in the year-ago quarter.
Net sales in the Hawthorne segment rose 41% year over year to $198.8 million in the reported quarter, which was primarily driven by strong demand in almost all categories of indoor growing equipment and supplies. The segment’s profit surged 216% year over year to $13.9 million.
Net sales in the Other segment fell 4% year over year to $19.6 million. The segment incurred a net loss of $3.5 million in the reported quarter, which is lower than a loss of $4 million in the year-ago quarter.
Balance Sheet
In fiscal first quarter, the company had cash and cash equivalents of $27.4 million, up 21.2% year over year. Long-term debt was $1,969.9 million, down 9.9% year over year.
Outlook
The company witnessed strong momentum in the U.S. Consumer unit in fiscal 2019, which also continued into fiscal 2020. Moreover, it continues to see outstanding performance across all product categories in the Hawthorne business in the United States.
Going forward, the company is upbeat on achieving its fiscal 2020 guidance. Scotts Miracle-Gro expects company-wide sales growth in the range of 4-6% for fiscal 2020. It continues to expect adjusted earnings per share in the band of $4.95-$5.15 for fiscal 2020.
Free cash flow is projected to be around $300 million.
Price Performance
Shares of Scotts Miracle-Gro have surged 61.8% in the past year against the industry’s 18.2% decline.
Zacks Rank & Key Picks
Scotts Miracle-Gro currently carries a Zacks Rank #3 (Hold).
Few better-ranked stocks in the basic materials space are Daqo New Energy Corp (DQ - Free Report) , Royal Gold, Inc (RGLD - Free Report) and Sibanye Gold Limited , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Daqo New Energy has projected earnings growth rate of 326.3% for 2020. The company’s shares have rallied 44.3% in the past year.
Royal Gold has an estimated earnings growth rate of 83.5% for fiscal 2020. Its shares have returned 32.5% in the past year.
Sibanye Gold has an expected earnings growth rate of 587.5% for 2020. The company’s shares surged 213.8% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>